A carregar...
A case report of disseminated verrucosis secondary to ustekinumab in a patient with Crohn’s disease
Ustekinumab is a biologic agent with Food and Drug Administration approval for the treatment of moderate-to-severe plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn’s disease. It functions to inhibit the p40 subunit common to both interleukin-12 and interleukin-23. These pro-infla...
Na minha lista:
| Publicado no: | SAGE Open Med Case Rep |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7975484/ https://ncbi.nlm.nih.gov/pubmed/33796316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X211003056 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|